Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...

The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The FDA has approved Journavx, an oral medication for treating pain that doesn't target the brain like addictive opioids.

The nonaddictive painkiller suzetrigine (Journavx) is as effective for acute pain as a common opioid treatment ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under the brand name Journavx.

A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...

Physician empathy has long been recommended — but not required — in the doctor-patient relationship.However, for a growing ...

Whether you’re trying to lose a few pounds or add some weight, smart scales that sync data to the iPhone and iPad can be a fun and useful way to keep an eye on your metrics. If you want to ...

However, when we asked, the doctor said that’s all she would prescribe (other than a similar narcotic) but that if he preferred, he could instead take over-the-counter medications like Tylenol or ...